Autopsy report · NCT01515813
Effect of HAART Vs. Statin Treatment on Endothelial Function and Inflammation/Coagulation
Cause of deathOther
“On 05/08/12, team working on revising protocol and re-open study under version 2.0”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Phase 2
- Sponsor
- Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
- Sponsor type
- University, hospital or other
- Conditions
- HIV-1 Infection
- Interventions
- Pravastatin sodium; Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate; Pravastatin sodium
- Participants
- 0
- Sites
- 9
- Countries
- United States
Trials that died the same way
- Safety and Effectiveness Study of RF Ablation of Uterine Fibroids to Reduce Menstrual Bleeding: the Fibroid Ablation Study
“study revised and reinitiated under another protocol” - Immunotherapy With N 803, ETBX-071, and M-CENK in Combination With Radiation for Participants With High-Risk Prostate Cancer.
“Study was redeveloped into a new protocol” - Effects of Whole Food, Plant-Based Nutrition on Chronic Kidney Disease With Proteinuria
“Substantially redesigning study protocol and opening a new study in the future.” - Estimate Serum Oxytocin PD Range in the Periphery
“Study will be replaced by a revised study protocol” - Characterization of Fecal Microbiome Changes After Administration of PRIM-DJ2727 in Parkinson's Disease Patients
“study will be started under a new modified protocol”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.